Today: 30 June 2026

Spotify Stock (SPOT) on December 8, 2025: Price, Latest News and 2026 Forecast

Spotify Stock (SPOT) on December 8, 2025: Price, Latest News and 2026 Forecast

As of Monday, December 8, 2025, Spotify Technology S.A. sits at the center of several market-moving headlines: a fresh round of U.S. price hikes, a looming leadership shake-up, record user engagement from Spotify Wrapped, and ongoing controversy over advertising policies. Together, these developments are shaping how investors think about Spotify’s 2026 outlook. By mid-afternoon U.S. trading on December 8, 2025, Spotify shares were changing hands at about $568, up roughly 0.5% on the day. That puts Spotify’s market capitalization near $117 billion, with trailing twelve‑month revenue of about $19.8 billion and net income of $1.65 billion.StockAnalysis
8 December 2025
··
Analog Devices (ADI) Stock Near Record Highs After Blowout Q4 2025 – Can the Rally Continue in 2026?

Analog Devices (ADI) Stock Near Record Highs After Blowout Q4 2025 – Can the Rally Continue in 2026?

Published: December 8, 2025 Analog Devices, Inc. is finishing 2025 on a high note. The analog chip specialist has just delivered a stronger‑than‑expected fourth quarter, issued upbeat guidance for early fiscal 2026, and is trading close to fresh 52‑week highs. At the same time, the stock now commands a rich valuation north of 60x trailing earnings, and a growing chorus of analysts and models are warning about limited upside – or even a near‑term pullback. Reuters+1
8 December 2025
·
CRH Stock Hits Record High on S&P 500 Inclusion: Latest News, Forecasts and 2026 Outlook (8 December 2025)

CRH Stock Hits Record High on S&P 500 Inclusion: Latest News, Forecasts and 2026 Outlook (8 December 2025)

New York / Dublin – December 8, 2025 CRH plc is closing out 2025 with a powerful combination of catalysts: confirmation it will join the S&P 500 later this month, fresh all‑time highs in its U.S. listing, an expanded buyback, and increasingly bullish analyst forecasts tied to U.S. infrastructure and low‑carbon construction trends. CRH+2Investing.com+2
8 December 2025
··
Hewlett Packard Enterprise (HPE) Stock Today: Q4 2025 Earnings, AI Factories and 2026 Outlook for Investors

Hewlett Packard Enterprise (HPE) Stock Today: Q4 2025 Earnings, AI Factories and 2026 Outlook for Investors

December 8, 2025 – Market overview and analysis, not investment advice. Hewlett Packard Enterprise Company shares are trading around $24 per share in today’s session, after a volatile few days following the company’s fiscal Q4 2025 earnings release. Real‑time data shows HPE changing hands at about $23.99, with an intraday range between roughly $23.06 and $24.36 as of late trading on December 8, 2025.
8 December 2025
··
ServiceNow (NOW) Stock on December 8, 2025: Split, Veza Deal and $110M AI Bet in Canada Drive Fresh Momentum

ServiceNow (NOW) Stock on December 8, 2025: Split, Veza Deal and $110M AI Bet in Canada Drive Fresh Momentum

December 8, 2025 — ServiceNow, Inc. is back in rally mode. The workflow and AI‑automation specialist is trading around $853 per share, with a market capitalization of roughly $177 billion, after extending its winning streak to seven consecutive sessions.GuruFocus+1 Investors today are digesting three major catalysts that are reshaping the ServiceNow stock story:
8 December 2025
···
Mastercard (MA) Stock on December 8, 2025: Analyst Upgrades, Swipe‑Fee Settlement and Q3 Earnings Shape the Outlook

Mastercard (MA) Stock on December 8, 2025: Analyst Upgrades, Swipe‑Fee Settlement and Q3 Earnings Shape the Outlook

Mastercard Incorporated is in focus on December 8, 2025, as fresh analyst upgrades, a landmark $38 billion swipe‑fee settlement and strong third‑quarter results converge to reshape the narrative around the payments giant’s stock. As of Monday’s U.S. session, Mastercard trades around $538.97, down roughly 1.2% on the day. That leaves the stock about 16% above its 52‑week low of $465.59 and roughly 10% below its 52‑week high of $601.77, giving the company a market value close to $490 billion and a trailing P/E near 35. MarketBeat+1
8 December 2025
··
Verizon (VZ) Stock on December 8, 2025: Near‑7% Dividend Yield, Deep Job Cuts and What Wall Street Expects Next

Verizon (VZ) Stock on December 8, 2025: Near‑7% Dividend Yield, Deep Job Cuts and What Wall Street Expects Next

Verizon Communications Inc. is back in the spotlight this week as investors digest a powerful mix of headlines: a fresh quarterly dividend, a sweeping management overhaul with thousands of job cuts, and steady—if unspectacular—growth in its core wireless and broadband business. As of early afternoon on Monday, December 8, 2025, Verizon stock is trading around $41–$41.25 per share, down about 1% on the day and modestly below last week’s highs.StockAnalysis+1 With a new annualized dividend of $2.76 per share, that puts the forward dividend yield at roughly 6.7%, making VZ one of the higher‑yielding blue‑chip stocks in the S&P 500.
8 December 2025
··
Ripple’s $500 Million Wall Street Deal: How a Hedged Bet on XRP Reshapes the Crypto–Finance Relationship

Ripple’s $500 Million Wall Street Deal: How a Hedged Bet on XRP Reshapes the Crypto–Finance Relationship

On 8 December 2025, new reporting from Bloomberg and The Block revealed the full contours of Ripple’s recent $500 million share sale — a transaction that has quietly become one of the most important bridges between Wall Street and crypto this cycle. The deal, completed in November at a $40 billion valuation, drew heavyweight investors including Citadel Securities, Fortress Investment Group, Brevan Howard–linked funds, Marshall Wace, Galaxy Digital and Pantera Capital.Bitget+1
8 December 2025
···
F-35 vs Saab Gripen: Jobs, Leaked Scores and Public Opinion Collide in Canada’s Fighter Jet Showdown

F-35 vs Saab Gripen: Jobs, Leaked Scores and Public Opinion Collide in Canada’s Fighter Jet Showdown

OTTAWA — December 8, 2025 — Canada’s long‑running quest to replace its aging CF‑18s has crystallized into a three‑way tug‑of‑war: a Swedish promise of 10,000 aerospace jobs, a leaked evaluation chart that overwhelmingly favours the U.S.‑made F‑35, and a fresh Nanos/CTV poll showing voters care more about getting the best fighter jet than maximizing domestic employment. At stake is far more than a single aircraft order. The decision will shape Canada’s defence industry, its relationship with the United States and Europe, and the Royal Canadian Air Force’s ability to defend North America for decades.
8 December 2025
·
Lumentum Holdings (LITE) Stock Forecast: AI Data Center Star Faces Valuation Jitters After 300% 2025 Rally

Lumentum Holdings (LITE) Stock Forecast: AI Data Center Star Faces Valuation Jitters After 300% 2025 Rally

Dateline: December 8, 2025 Lumentum Holdings Inc. has turned from a niche optical components maker into one of the stock market’s loudest AI-infrastructure stories in 2025. As of the afternoon of December 8, 2025, Lumentum shares trade around the mid‑$340s, near their all‑time highs, giving the company a market cap of roughly $24 billion and a trailing P/E above 200. StockAnalysis+1
8 December 2025
·
Texas Instruments (TXN) Stock on December 8, 2025: Q3 Beat, $60 Billion U.S. Fab Plan and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 8, 2025: Q3 Beat, $60 Billion U.S. Fab Plan and What Wall Street Expects Next

Texas Instruments Incorporated is closing out 2025 as one of the most hotly debated blue‑chip semiconductor stocks: fundamentally solid, generous with dividends, but under pressure from heavy capital spending and a cooler‑than‑hoped earnings outlook. Below is a structured look at where Texas Instruments stock stands today, the latest earnings, its $60+ billion U.S. manufacturing bet, and how analysts and big investors are positioning as of December 8, 2025.
8 December 2025
··
Lazard, Inc. (LAZ) Stock on 8 December 2025: Q3 Beat, Strategic Expansion and a Sharp Sell‑Off – What It All Means for Investors

Lazard, Inc. (LAZ) Stock on 8 December 2025: Q3 Beat, Strategic Expansion and a Sharp Sell‑Off – What It All Means for Investors

As of the close of trading on 8 December 2025, Lazard, Inc. is a curious mix of strong operating momentum, ambitious long‑term targets and a suddenly weaker share price. LAZ recently traded around $50.9, down roughly 7% on the day from a prior close near $54.75, according to intraday quote data and MarketBeat’s real‑time feed. MarketBeat Earlier in Monday’s session, the stock was highlighted as trading down about 4.7% on unusually light volume, with only ~114,000 shares changing hands versus a typical volume of around 1.0 million. MarketBeat
8 December 2025
·
Pfizer (PFE) Stock Today: Hemophilia Breakthrough, Metsera Deal and AI Cost Cuts – Price, Forecast and News for December 8, 2025

Pfizer (PFE) Stock Today: Hemophilia Breakthrough, Metsera Deal and AI Cost Cuts – Price, Forecast and News for December 8, 2025

Pfizer Inc. is back in focus on December 8, 2025, as investors digest fresh clinical data in hemophilia, big strategic bets in obesity drugs, and an aggressive, AI‑driven cost‑cutting program – all while the stock continues to trade at a high dividend yield and a discount to many Big Pharma peers. As of Monday morning, Pfizer shares are trading around $26 per share, slightly lower on the day and roughly in the middle of their 52‑week range of $20.92–$27.69. That range implies a market capitalization of about $148 billion, a price‑to‑earnings ratio near 15x, and relatively low share‑price volatility. MarketBeat+1
8 December 2025
···
Life360 (ASX:360, Nasdaq:LIF) Stock on 8 December 2025: Q3 Beat, Nativo Deal, Sell‑Off and 2026 Forecasts

Life360 (ASX:360, Nasdaq:LIF) Stock on 8 December 2025: Q3 Beat, Nativo Deal, Sell‑Off and 2026 Forecasts

8 December 2025 – Life360, Inc., the family safety and location‑sharing platform behind the Life360 app and Tile trackers, is having another volatile day on the markets despite reporting record third‑quarter results and announcing a major ad‑tech acquisition. On the ASX, Life360 closed at A$37.83, down 3.84% and listed among the biggest losers in the ASX 300 on Monday’s session.StockInvest+1 On Nasdaq, Life360’s U.S. line was recently trading around US$73.18, with intraday trades between US$71.90 and US$78.01.
8 December 2025
··
Gilead Sciences (GILD) Stock Today: Price, Fresh News and Analyst Outlook on December 8, 2025

Gilead Sciences (GILD) Stock Today: Price, Fresh News and Analyst Outlook on December 8, 2025

As of Monday, December 8, 2025, Gilead Sciences, Inc. sits near the upper end of its 52‑week range, supported by strong HIV franchises, new long‑acting prevention drugs, high‑profile cancer data at ASH 2025 and a steady dividend. At the same time, investors are weighing slowing COVID‑19 sales, competitive oncology pressures and policy risk. Below is a structured look at today’s price action, the latest news flow dated December 8, 2025, analyst forecasts and the medium‑term investment narrative around Gilead Sciences stock.
8 December 2025
1 … 1,535 1,536 1,537 1,538 1,539 … 2,124

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Go toTop